Ampullary carcinoma: an overview of a rare entity and discussion of current and future therapeutic challenges

A Rizzo, V Dadduzio, L Lombardi, AD Ricci… - Current …, 2021 - mdpi.com
Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all
gastrointestinal solid tumors and 20% of all periampullary cancers (PACs). Unfortunately …

Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives

G Nappo, N Funel, V Laurenti, E Stenner, S Carrara… - Current …, 2023 - mdpi.com
There are different cancers in the peri-ampullary region, including pancreatic ductal
adenocarcinoma (PDAC), duodenum cancers (DCs), and ampullary adenocarcinoma …

Impact of histopathological type on the prognosis of ampullary carcinoma: A systematic review and meta-analysis

DW Shin, S Kim, K Jung, JH Jung, B Kim, J Ahn… - European Journal of …, 2023 - Elsevier
Histologically, ampullary carcinomas (ACs) can be classified into intestinal (INT-AC) and
pancreatobiliary (PB-AC) subtypes. However, the prognostic implications of these subtypes …

The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study

BA Uijterwijk, DH Lemmers, M Ghidini… - British Journal of …, 2024 - nature.com
Background Despite differences in tumour behaviour and characteristics between duodenal
adenocarcinoma (DAC), the intestinal (AmpIT) and pancreatobiliary (AmpPB) subtype of …

Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary …

G Nappo, J Galvanin, D Gentile, G Capretti, A Pulvirenti… - Pancreatology, 2021 - Elsevier
Background Ampullary carcinoma (AC) is histologically classified as intestinal (In-AC),
pancreaticobiliary (Pb-AC) or mixed-AC. The prognostic role of AC subtypes has been …

[HTML][HTML] Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: a systematic review

Z Duan, Y Zhang, Y Tang, R Gao, J Bao, B Liang - Translational Oncology, 2022 - Elsevier
Objective This review investigates the role of adjuvant therapy (AT) and the importance of
histopathological typing in periampullary carcinoma (PAC) treatment. Background PAC is a …

Impact of circumferential resection margin on survival in ampullary cancer: retrospective analysis

A Nießen, M Loos, K Neumüller, M Feißt, U Klaiber… - BJS open, 2023 - academic.oup.com
Background Ampullary carcinoma is a clinically variable entity. This study aimed to evaluate
prognostic factors for the outcome of resected ampullary carcinoma patients with particular …

Identification of patients at high risk for recurrence in carcinoma of the ampulla of Vater: Analysis in 460 patients

M Narita, E Hatano, K Kitamura… - Annals of …, 2024 - Wiley Online Library
Aim Carcinoma of the ampulla of Vater (CAV) shows a favorable prognosis compared to that
with the other periampullary tumors, while some cases have a poor prognosis. The aims of …

[HTML][HTML] The diagnosis and treatment of ampullary carcinoma

D Walter, AA Schnitzbauer, F Schulze… - Deutsches Ärzteblatt …, 2023 - ncbi.nlm.nih.gov
Background Ampullary or papillary carcinoma is a malignant tumor arising from the mucosa
in the region of the major duodenal papilla, also known as the ampulla of Vater. Uniform …

Ampullary adenocarcinoma, version 1.2023, NCCN clinical practice guidelines in oncology

EG Chiorean, M Del Chiaro, MA Tempero… - Journal of the National …, 2023 - jnccn.org
Ampullary cancers refer to tumors originating from the ampulla of Vater (the ampulla, the
intraduodenal portion of the bile duct, and the intraduodenal portion of the pancreatic duct) …